Bristol-Myers Squibb (Germany)
In research, Bristol-Myers Squibb (Germany) stands highest in Life Sciences (#4,355 of 7,800 worldwide), Medicine (#6,915 of 10,443 worldwide) and Health Sciences (#8,680 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 7.7× its share of world research.
- World rank, 2022–2025
- #7,764 of 28,054 · #2,400 all time
- Rank in Germany
- #315 of 1,178
- Research works
- 2.6k ▼ 31% vs 2013–17
- Citations
- 116k 44.8 per fractional work
- Top-10% rate
- 15.3% record average 16.5%
- Open access
- 34% world 28%
What is Bristol-Myers Squibb (Germany) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #4,355 of 7,800 | 13.0% | 70 | #1193 | |
| MedicineField | #6,915 of 10,443 | 15.4% | 89 | #1128 | |
| Health SciencesDomain | #8,680 of 11,982 | 15.3% | 91 | #1477 |
Each strip is that field’s whole ranked pool, with the notch where Bristol-Myers Squibb (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#1,193 #4,355
- Medicine#1,128 #6,915
- Health Sciences#1,477 #8,680
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Bristol-Myers Squibb (Germany) specialise in?
Where its research is concentrated relative to its size: Oncology takes 7.7× the share of its output that it takes of world research.
- OncologySubfield · 20.2 works7.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.7×
- Chemistry 6.0×
- Immunology and Microbiology 6.0×
- Biochemistry, Genetics and Molecular Biology 3.8×
- Mathematics 2.7×
- Medicine 2.0×
- Decision Sciences 1.9×
- Economics, Econometrics and Finance 1.6×
- Chemical Engineering 0.8×
- Neuroscience 0.7×
- Materials Science 0.4×
- Veterinary 0.4×
- Psychology 0.4×
- Engineering 0.3×
- Health Professions 0.3×
- Computer Science 0.2×
- Nursing 0.2×
- Dentistry 0.2×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Energy 0.1×
- Agricultural and Biological Sciences 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Bristol-Myers Squibb (Germany)?
Ranked on the composite score, Rashmi H. Barbhaiya, Michael L. Doyle and Kelly Pittman lead among researchers whose main affiliation is Bristol-Myers Squibb (Germany).
- 1 Rashmi H. Barbhaiya Germany · #551,542 worldwide 44 citations · 17 works
- 2 Michael L. Doyle Germany · #559,337 worldwide 94 citations · 18 works
- 3 Kelly Pittman Germany · #1,257,490 worldwide 28 citations · 15 works
Which keywords describe research at Bristol-Myers Squibb (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Tumor Microenvironment, Biopharmaceuticals, Immunogenicity, Immunotherapy and Lymphoma.
- Immune System
- False Discovery Rate
- PD-1 and PD-L1
- Transition Metal Catalysis
- PET Imaging
- Targeted Therapy
- CAR T Cells
- Tumor Regression
- Bayesian Methods
- Monoclonal Antibody
- Antibody Engineering
- Chromatography
- Stability
- Prognostic Factors
- Clinical Trials
- Lymphoma
- Cancer
- Immunogenicity
- Tumor Microenvironment
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Biopharmaceuticals
- Inflammation
- Immunotherapy
- Biomarkers
- Cancer Immunotherapy
- Chemotherapy
- Recombinant Proteins
- Protein Aggregation
- Fc Receptors
- Cell Culture
- Transcriptional Regulation
- Biopharmaceutical Production
- Chimeric Antigen Receptor
- Mammalian Cells
- Recombinant Protein
- Immune Checkpoint Blockade
- Adaptive Designs
- TGF-ß
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Monoclonal Antibodies16▲ 76×3 topics
- Therapeutic Antibodies13▲ 78×2 topics
- Glycosylation12▲ 46×3 topics
- Tumor Microenvironment10▲ 9.9×6 topics
- Biopharmaceuticals10▲ 81×3 topics
- Immunogenicity10▲ 97×2 topics
- Inflammation10▲ 1.98×40 topics
- Cancer9▲ 2.9×31 topics
- Immunotherapy9▲ 5.5×15 topics
- Lymphoma7▲ 20×3 topics
- Biomarkers7▲ 4.4×12 topics
- Clinical Trials7▲ 4.5×11 topics
- Cancer Immunotherapy7▲ 19×3 topics
- Prognostic Factors7▲ 6.7×9 topics
- Chemotherapy7▲ 4.1×17 topics
- Stability7▲ 13×3 topics
- Recombinant Proteins7▲ 91×2 topics
- Chromatography7▲ 189×1 topic
- Protein Aggregation7▲ 54×1 topic
- Antibody Engineering6▲ 48×1 topic
- Fc Receptors6▲ 48×1 topic
- Monoclonal Antibody6▲ 50×2 topics
- Cell Culture6▲ 22×2 topics
- Bayesian Methods6▲ 49×2 topics
- Transcriptional Regulation6▲ 15×8 topics
- Tumor Regression6▲ 21×2 topics
- Biopharmaceutical Production5▲ 55×2 topics
- CAR T Cells5▲ 31×1 topic
- Chimeric Antigen Receptor5▲ 31×1 topic
- Targeted Therapy5▲ 9.8×5 topics
- Mammalian Cells5▲ 90×1 topic
- PET Imaging5▲ 13×4 topics
- Recombinant Protein5▲ 90×1 topic
- Transition Metal Catalysis5▲ 25×4 topics
- Immune Checkpoint Blockade5▲ 19×1 topic
- PD-1 and PD-L15▲ 19×1 topic
- Adaptive Designs5▲ 98×1 topic
- False Discovery Rate5▲ 98×1 topic
- TGF-ß5▲ 13×4 topics
- Immune System4▲ 8.1×5 topics
Which research topics does Bristol-Myers Squibb (Germany) publish most on?
By volume in 2022–2025: Protein purification and stability, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein purification and stability Molecular Biology 7 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 6 works
- 3 CAR-T cell therapy research Oncology 5 works
- 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 5 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 6 Statistical Methods in Clinical Trials Statistics and Probability 5 works
- 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 8 Protein Degradation and Inhibitors Molecular Biology 3 works
- 9 Multiple Myeloma Research and Treatments Hematology 3 works
- 10 Psoriasis: Treatment and Pathogenesis Immunology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bristol-Myers Squibb (Germany)'s research output changed?
Output in 2018–2022 was 31% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Munich
- Ludwig-Maximilians-Universität München
- Max Planck Society
- Technical University of Munich
- Siemens (Germany)
- München Klinik
- LMU Klinikum
- Munich University of Applied Sciences
- TUM Klinikum
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.